BR0317282A - Derivados de 3h-quinazolin-4-ona - Google Patents
Derivados de 3h-quinazolin-4-onaInfo
- Publication number
- BR0317282A BR0317282A BR0317282-1A BR0317282A BR0317282A BR 0317282 A BR0317282 A BR 0317282A BR 0317282 A BR0317282 A BR 0317282A BR 0317282 A BR0317282 A BR 0317282A
- Authority
- BR
- Brazil
- Prior art keywords
- quinazolin
- derivatives
- inhibitors
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Abstract
"DERIVADOS DE 3H-QUINAZOLIN-4-ONA". Esta invenção refere-se a derivados de 3H-quinazolin-4-ona, como definidos no relatório descritivo e nas reivindicações, a um processo para sua preparação, a composições farmacêuticas que os contêm, e a seu uso como inibidores seletivos de monoamina oxidase B.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02027700 | 2002-12-13 | ||
PCT/EP2003/013888 WO2004054985A1 (en) | 2002-12-13 | 2003-12-08 | 3h-quinazolin-4-one derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0317282A true BR0317282A (pt) | 2005-11-08 |
Family
ID=32524001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0317282-1A BR0317282A (pt) | 2002-12-13 | 2003-12-08 | Derivados de 3h-quinazolin-4-ona |
Country Status (23)
Country | Link |
---|---|
US (1) | US7087612B2 (pt) |
EP (1) | EP1572666B1 (pt) |
JP (1) | JP4384053B2 (pt) |
KR (1) | KR100707532B1 (pt) |
CN (1) | CN100418954C (pt) |
AR (1) | AR042362A1 (pt) |
AT (1) | ATE335729T1 (pt) |
AU (1) | AU2003293798B8 (pt) |
BR (1) | BR0317282A (pt) |
CA (1) | CA2509633A1 (pt) |
CL (1) | CL2003002565A1 (pt) |
DE (1) | DE60307512T2 (pt) |
ES (1) | ES2270154T3 (pt) |
GT (1) | GT200300284A (pt) |
MX (1) | MXPA05006124A (pt) |
MY (1) | MY141743A (pt) |
PA (1) | PA8591901A1 (pt) |
PE (1) | PE20040911A1 (pt) |
PL (1) | PL377474A1 (pt) |
RU (1) | RU2340604C2 (pt) |
TW (1) | TW200424180A (pt) |
UY (1) | UY28120A1 (pt) |
WO (1) | WO2004054985A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7846915B2 (en) | 2004-10-20 | 2010-12-07 | Resverlogix Corporation | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
RU2007129642A (ru) | 2005-02-25 | 2009-03-27 | Ф.Хоффманн-Ля Рош Аг (Ch) | Таблетки с улучшенным распределением лекарственного вещества |
CA2617213C (en) | 2005-07-29 | 2014-01-28 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
GB0525068D0 (en) * | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
JP4876690B2 (ja) * | 2006-04-21 | 2012-02-15 | 三菱瓦斯化学株式会社 | キナゾリン−4−オン誘導体の製造法 |
EP2123627B1 (en) * | 2007-01-19 | 2013-11-20 | Ube Industries, Ltd. | Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group |
NZ579355A (en) | 2007-02-01 | 2012-03-30 | Resverlogix Corp | 2-(Aryl)-4-oxo-quinazoline derivatives |
EP2346837B8 (en) | 2008-06-26 | 2015-04-15 | Resverlogix Corporation | Methods of preparing quinazolinone derivatives |
EP2660238B1 (en) | 2009-01-08 | 2015-05-06 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular disease |
KR101803259B1 (ko) | 2009-03-18 | 2017-11-30 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
BRPI1014956B8 (pt) | 2009-04-22 | 2021-05-25 | Resverlogix Corp | agentes anti-inflamatórios |
LT2773354T (lt) | 2011-11-01 | 2019-08-12 | Resverlogix Corp. | Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos |
WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
MX2015007921A (es) | 2012-12-21 | 2016-03-03 | Zenith Epigenetics Corp | Compuestos heterociclicos novedosos como inhibidores de bromodominio. |
EP3268007B1 (en) | 2015-03-13 | 2022-11-09 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
CN106146410B (zh) * | 2015-04-03 | 2018-10-12 | 中南大学 | 6-氨基-4(3h)-喹唑啉酮衍生物及其合成方法和用途 |
CN108191667B (zh) * | 2018-01-04 | 2021-03-26 | 利尔化学股份有限公司 | 2-硝基-4-三氟甲基苯甲酸甲酯的制备方法 |
CN109553534A (zh) * | 2018-11-27 | 2019-04-02 | 常州大学 | 一种2-硝基-4-甲氧基苯甲酸的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6136273A (ja) * | 1984-07-26 | 1986-02-20 | Mitsubishi Yuka Yakuhin Kk | 2−フエニルアルキル−4(3h)−キナゾリノン誘導体 |
US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
JP3258027B2 (ja) | 1996-03-15 | 2002-02-18 | サマーセット・ファーマシューティカルズ・インコーポレイテッド | セレジリン投与による末梢ニューロパシーの予防および治療方法 |
DE69838172T2 (de) * | 1997-08-22 | 2008-04-10 | Astrazeneca Ab | Oxindolylchinazolinderivate als angiogenesehemmer |
US6890930B1 (en) * | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
AU1359801A (en) | 1999-11-05 | 2001-06-06 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-12-08 RU RU2005121908/04A patent/RU2340604C2/ru not_active IP Right Cessation
- 2003-12-08 PL PL377474A patent/PL377474A1/pl not_active Application Discontinuation
- 2003-12-08 KR KR1020057010696A patent/KR100707532B1/ko not_active IP Right Cessation
- 2003-12-08 CN CNB2003801052982A patent/CN100418954C/zh not_active Expired - Fee Related
- 2003-12-08 AT AT03789170T patent/ATE335729T1/de not_active IP Right Cessation
- 2003-12-08 MX MXPA05006124A patent/MXPA05006124A/es active IP Right Grant
- 2003-12-08 ES ES03789170T patent/ES2270154T3/es not_active Expired - Lifetime
- 2003-12-08 EP EP03789170A patent/EP1572666B1/en not_active Expired - Lifetime
- 2003-12-08 JP JP2004559781A patent/JP4384053B2/ja not_active Expired - Lifetime
- 2003-12-08 AU AU2003293798A patent/AU2003293798B8/en not_active Ceased
- 2003-12-08 WO PCT/EP2003/013888 patent/WO2004054985A1/en active IP Right Grant
- 2003-12-08 BR BR0317282-1A patent/BR0317282A/pt not_active IP Right Cessation
- 2003-12-08 CA CA002509633A patent/CA2509633A1/en not_active Abandoned
- 2003-12-08 DE DE60307512T patent/DE60307512T2/de not_active Expired - Lifetime
- 2003-12-09 TW TW092134699A patent/TW200424180A/zh unknown
- 2003-12-10 CL CL200302565A patent/CL2003002565A1/es unknown
- 2003-12-10 PA PA20038591901A patent/PA8591901A1/es unknown
- 2003-12-10 PE PE2003001256A patent/PE20040911A1/es not_active Application Discontinuation
- 2003-12-11 AR ARP030104562A patent/AR042362A1/es unknown
- 2003-12-11 UY UY28120A patent/UY28120A1/es not_active Application Discontinuation
- 2003-12-11 GT GT200300284A patent/GT200300284A/es unknown
- 2003-12-12 MY MYPI20034764A patent/MY141743A/en unknown
- 2003-12-13 US US10/734,949 patent/US7087612B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MY141743A (en) | 2010-06-30 |
US20040142951A1 (en) | 2004-07-22 |
KR100707532B1 (ko) | 2007-04-12 |
PA8591901A1 (es) | 2004-11-26 |
US7087612B2 (en) | 2006-08-08 |
JP4384053B2 (ja) | 2009-12-16 |
GT200300284A (es) | 2004-07-14 |
DE60307512D1 (de) | 2006-09-21 |
ES2270154T3 (es) | 2007-04-01 |
UY28120A1 (es) | 2004-06-30 |
AU2003293798B2 (en) | 2009-01-15 |
RU2340604C2 (ru) | 2008-12-10 |
KR20050085587A (ko) | 2005-08-29 |
AU2003293798B8 (en) | 2009-02-12 |
CN100418954C (zh) | 2008-09-17 |
PE20040911A1 (es) | 2004-12-11 |
WO2004054985A1 (en) | 2004-07-01 |
EP1572666A1 (en) | 2005-09-14 |
RU2005121908A (ru) | 2006-01-27 |
CA2509633A1 (en) | 2004-07-01 |
AU2003293798A1 (en) | 2004-07-09 |
CN1720237A (zh) | 2006-01-11 |
JP2006513177A (ja) | 2006-04-20 |
CL2003002565A1 (es) | 2005-01-07 |
AR042362A1 (es) | 2005-06-15 |
ATE335729T1 (de) | 2006-09-15 |
MXPA05006124A (es) | 2005-08-16 |
EP1572666B1 (en) | 2006-08-09 |
TW200424180A (en) | 2004-11-16 |
PL377474A1 (pl) | 2006-02-06 |
DE60307512T2 (de) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0317282A (pt) | Derivados de 3h-quinazolin-4-ona | |
BR0313041A (pt) | Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos | |
BR0111667A (pt) | Novos compostos | |
PT1339675E (pt) | Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem | |
BRPI0512986A (pt) | novos derivados de hidantoìna | |
SV2001000004A (es) | Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa | |
CR8858A (es) | Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados | |
BRPI0312649A2 (pt) | compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos. | |
CR7828A (es) | Oxialquilamidas de quinolina, isoquinolina y quinazolina y su uso como fungicidas | |
BR9916004A (pt) | Inibidores de proteinase c de pró-colágeno | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
BRPI0510931A (pt) | derivados de sulfamato e sulfamida para o tratamento de epilepsia e distúrbios relacionados | |
BR9915013A (pt) | Composto, uso dos mesmos, processo para preparar os mesmos, droga, e, método para detecção in vitro para inibidores parp | |
BR0017030B8 (pt) | derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos | |
BR0011489A (pt) | Composições formadoras de pelìcula compreendendo amidos modificados e iota-carragenano e processos para a fabricação de cápsulas macias usando as mesmas | |
BR0315296A (pt) | Derivados do ciclohexanol espirocìclicos | |
NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
AR025244A1 (es) | Uso de inhibidores de monoamina oxidasa para la elaboracion de farmacos destinados al tratamiento de la obesidad | |
BRPI0407734A (pt) | derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo | |
BRPI0413094A (pt) | derivados de quinolina e seu uso em terapia | |
BRPI0518841A2 (pt) | derivados de indenila e uso destes para o tratamento de transtornos neurolàgicos | |
BR0307461A (pt) | Derivados de quinazolinona e seu uso como agonistas de cb | |
BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
PT1560826E (pt) | Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem | |
PT1122254E (pt) | Derivados de 4-sulfonamidas piperidina, processo para a sua preparacao e as composicoes farmaceuticas que os contem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |